Evaluation of dysphagia following radiotherapy and radiotherapy combined with chemotherapy as a treatment in oral cancer patients
- Conditions
- Health Condition 1: C101- Malignant neoplasm of anterior surface of epiglottisHealth Condition 2: C102- Malignant neoplasm of lateral wallof oropharynxHealth Condition 3: C109- Malignant neoplasm of oropharynx,unspecifiedHealth Condition 4: C108- Malignant neoplasm of overlappingsites of oropharynxHealth Condition 5: C103- Malignant neoplasm of posterior wall of oropharynxHealth Condition 6: C100- Malignant neoplasm of vallecula
- Registration Number
- CTRI/2024/01/061754
- Lead Sponsor
- Dr Kundana Devalla
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1)Carcinoma oropharynx patients with histologically proven squamous cell carcinoma and are planned for radiotherapy with or without chemotherapy with a curative intent
2)patients of age greater than 18 years
1)Patients less than 18 years of age and greater than 75 years of age
2)Patients with underlying conditions such as stroke , dementia, neuromuscular diseases, that had already caused or may cause dysphagia
3)Head and neck cancers other than oropharynx as the primary site
4)Any prior surgery or radiotherapy with or without chemotherapy for head and neck neoplasms
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of the dysphagia with the concomitant use of chemo-radiotherapy in oropharyngeal <br/ ><br>carcinoma patientsTimepoint: 6 Months
- Secondary Outcome Measures
Name Time Method 1)Early identification and prevention of potential complications such as respiratory issues due <br/ ><br>to aspiration and malnutrition <br/ ><br>2)Provide reassurance and encourage the patient to seek an evaluation /consultation with a <br/ ><br>speech and swallowing therapist.Timepoint: 6 Months